Eyegate (EYEG) Surges on New 'Buy' Rating
Tweet
Share
E-mailGet Alerts EYEG Hot Sheet
Price: $34.50 -0.06%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Eyegate Pharmaceuticals (NASDAQ: EYEG) is surging 66% in early trade after Rodman & Renshaw initiated coverage on with a Buy rating and a price target of $10.00.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Starts Tier IV Inc (593A:JP) at Overweight
- Evercore ISI Starts MongoDB (MDB) at Outperform
- Buyout firm Vista explores $3B sale of private markets data provider Allvue - Reuters
Create E-mail Alert Related Categories
Hot New Coverage, Momentum Movers, New Coverage, Trader TalkRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
